Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury

The intrinsic ability of peripheral nerves to regenerate after injury is extremely limited, especially in case of severe injury. This often leads to poor motor function and permanent disability. Existing approaches for the treatment of injured nerves do not provide appropriate conditions to support...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kamilla Faritovna Idrisova, Alina Kazymovna Zeinalova, Galina Andreevna Masgutova, Alexey Andreevich Bogov, Cinzia Allegrucci, Valeriia Yurievna Syromiatnikova, Ilnur Ildusovich Salafutdinov, Ekaterna Evgenievna Garanina, Dina Ivanovna Andreeva, Adilet Abdullaatovich Kadyrov, Albert Anatolevich Rizvanov, Ruslan Faridovich Masgutov
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2022
Materias:
Acceso en línea:https://doaj.org/article/823d77f63fbd44699b9b7c6b94f52854
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:823d77f63fbd44699b9b7c6b94f52854
record_format dspace
spelling oai:doaj.org-article:823d77f63fbd44699b9b7c6b94f528542021-11-19T12:16:44ZApplication of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury1673-537410.4103/1673-5374.327329https://doaj.org/article/823d77f63fbd44699b9b7c6b94f528542022-01-01T00:00:00Zhttp://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=6;spage=1240;epage=1247;aulast=Idrisovahttps://doaj.org/toc/1673-5374The intrinsic ability of peripheral nerves to regenerate after injury is extremely limited, especially in case of severe injury. This often leads to poor motor function and permanent disability. Existing approaches for the treatment of injured nerves do not provide appropriate conditions to support survival and growth of nerve cells. This drawback can be compensated by the use of gene therapy and cell therapy-based drugs that locally provide an increase in the key regulators of nerve growth, including neurotrophic factors and extracellular matrix proteins. Each growth factor plays its own specific angiotrophic or neurotrophic role. Currently, growth factors are widely studied as accelerators of nerve regeneration. Particularly noteworthy is synergy between various growth factors, that is essential for both angiogenesis and neurogenesis. Fibroblast growth factor 2 and vascular endothelial growth factor are widely known for their proangiogenic effects. At the same time, fibroblast growth factor 2 and vascular endothelial growth factor stimulate neural cell growth and play an important role in neurodegenerative diseases of the peripheral nervous system. Taken together, their neurotrophic and angiogenic properties have positive effect on the regeneration process. In this review we provide an in-depth overview of the role of fibroblast growth factor 2 and vascular endothelial growth factor in the regeneration of peripheral nerves, thus demonstrating their neurotherapeutic efficacy in improving neuron survival in the peripheral nervous system.Kamilla Faritovna IdrisovaAlina Kazymovna ZeinalovaGalina Andreevna MasgutovaAlexey Andreevich BogovCinzia AllegrucciValeriia Yurievna SyromiatnikovaIlnur Ildusovich SalafutdinovEkaterna Evgenievna GaraninaDina Ivanovna AndreevaAdilet Abdullaatovich KadyrovAlbert Anatolevich RizvanovRuslan Faridovich MasgutovWolters Kluwer Medknow Publicationsarticlefibroblast growth factor 2; growth factors; nerve growth factor; peripheral nerve injury; peripheral nervous system; vascular endothelial growth factorNeurology. Diseases of the nervous systemRC346-429ENNeural Regeneration Research, Vol 17, Iss 6, Pp 1240-1247 (2022)
institution DOAJ
collection DOAJ
language EN
topic fibroblast growth factor 2; growth factors; nerve growth factor; peripheral nerve injury; peripheral nervous system; vascular endothelial growth factor
Neurology. Diseases of the nervous system
RC346-429
spellingShingle fibroblast growth factor 2; growth factors; nerve growth factor; peripheral nerve injury; peripheral nervous system; vascular endothelial growth factor
Neurology. Diseases of the nervous system
RC346-429
Kamilla Faritovna Idrisova
Alina Kazymovna Zeinalova
Galina Andreevna Masgutova
Alexey Andreevich Bogov
Cinzia Allegrucci
Valeriia Yurievna Syromiatnikova
Ilnur Ildusovich Salafutdinov
Ekaterna Evgenievna Garanina
Dina Ivanovna Andreeva
Adilet Abdullaatovich Kadyrov
Albert Anatolevich Rizvanov
Ruslan Faridovich Masgutov
Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
description The intrinsic ability of peripheral nerves to regenerate after injury is extremely limited, especially in case of severe injury. This often leads to poor motor function and permanent disability. Existing approaches for the treatment of injured nerves do not provide appropriate conditions to support survival and growth of nerve cells. This drawback can be compensated by the use of gene therapy and cell therapy-based drugs that locally provide an increase in the key regulators of nerve growth, including neurotrophic factors and extracellular matrix proteins. Each growth factor plays its own specific angiotrophic or neurotrophic role. Currently, growth factors are widely studied as accelerators of nerve regeneration. Particularly noteworthy is synergy between various growth factors, that is essential for both angiogenesis and neurogenesis. Fibroblast growth factor 2 and vascular endothelial growth factor are widely known for their proangiogenic effects. At the same time, fibroblast growth factor 2 and vascular endothelial growth factor stimulate neural cell growth and play an important role in neurodegenerative diseases of the peripheral nervous system. Taken together, their neurotrophic and angiogenic properties have positive effect on the regeneration process. In this review we provide an in-depth overview of the role of fibroblast growth factor 2 and vascular endothelial growth factor in the regeneration of peripheral nerves, thus demonstrating their neurotherapeutic efficacy in improving neuron survival in the peripheral nervous system.
format article
author Kamilla Faritovna Idrisova
Alina Kazymovna Zeinalova
Galina Andreevna Masgutova
Alexey Andreevich Bogov
Cinzia Allegrucci
Valeriia Yurievna Syromiatnikova
Ilnur Ildusovich Salafutdinov
Ekaterna Evgenievna Garanina
Dina Ivanovna Andreeva
Adilet Abdullaatovich Kadyrov
Albert Anatolevich Rizvanov
Ruslan Faridovich Masgutov
author_facet Kamilla Faritovna Idrisova
Alina Kazymovna Zeinalova
Galina Andreevna Masgutova
Alexey Andreevich Bogov
Cinzia Allegrucci
Valeriia Yurievna Syromiatnikova
Ilnur Ildusovich Salafutdinov
Ekaterna Evgenievna Garanina
Dina Ivanovna Andreeva
Adilet Abdullaatovich Kadyrov
Albert Anatolevich Rizvanov
Ruslan Faridovich Masgutov
author_sort Kamilla Faritovna Idrisova
title Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
title_short Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
title_full Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
title_fullStr Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
title_full_unstemmed Application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
title_sort application of neurotrophic and proangiogenic factors as therapy after peripheral nervous system injury
publisher Wolters Kluwer Medknow Publications
publishDate 2022
url https://doaj.org/article/823d77f63fbd44699b9b7c6b94f52854
work_keys_str_mv AT kamillafaritovnaidrisova applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT alinakazymovnazeinalova applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT galinaandreevnamasgutova applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT alexeyandreevichbogov applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT cinziaallegrucci applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT valeriiayurievnasyromiatnikova applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT ilnurildusovichsalafutdinov applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT ekaternaevgenievnagaranina applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT dinaivanovnaandreeva applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT adiletabdullaatovichkadyrov applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT albertanatolevichrizvanov applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
AT ruslanfaridovichmasgutov applicationofneurotrophicandproangiogenicfactorsastherapyafterperipheralnervoussysteminjury
_version_ 1718420078981021696